Rosen

Rosen Law Firm Initiates Class Action Lawsuit Against Match Group Over Alleged Misstatements, Invites Investors to Join

by

New York – The Rosen Law Firm, a global leader in investor rights litigation, has initiated a class action lawsuit against Match Group, Inc., alleging that the company made false and misleading statements regarding its operations, particularly affecting its service Tinder. The lawsuit encompasses those who purchased Match Group securities between May 2, 2023, and November 6, 2024. Investors who acquired Match Group securities within this period may be eligible for compensation through a contingency fee arrangement, irrespective of any out-of-pocket expenses. The aim of the lawsuit is to hold Match Group accountable for purportedly … Read more

Rosen Law Firm Announces Key Deadline in Edwards Lifesciences Securities Class Action – Investors Urged to Act by December 13

by

New York — The Rosen Law Firm, recognized globally for defending investor rights, is currently notifying investors of the impending lead plaintiff deadline on December 13, 2024, in the class action lawsuit against Edwards Lifesciences Corporation. This lawsuit pertains to all individuals who acquired securities in Edwards between February 6, 2024, and July 24, 2024. These investors might be eligible for monetary recovery via a contingency fee arrangement, requiring no out-of-pocket fees. Edwards Lifesciences, listed under NYSE: EW, is primarily involved through its innovations in patient-focused medical innovations, including the critical Transcatheter Aortic Valve Replacement … Read more

Deadline Alert: Rosen Law Firm Reminds Edwards Lifesciences Investors of Upcoming Lead Plaintiff Deadline in Securities Class Action Lawsuit

by

NEW YORK — Rosen Law Firm, renowned for championing global investor rights, has issued a reminder about the impending lead plaintiff deadline of December 13, 2024, for those who acquired securities from Edwards Lifesciences Corporation during the period of February 6, 2024, to July 24, 2024. This deadline is crucial for investors who believe they have suffered losses due to potential misinformation by Edwards Lifesciences regarding their financial forecasts and product performance. Investors who have bought Edwards securities within this specified period may be eligible for compensation without the necessity of any out-of-pocket fees or … Read more

Rosen Law Firm Announces Key Deadline in Edwards Lifesciences Securities Class Action – Investors Urged to Act by December 13

by

New York — Investors who purchased securities from Edwards Lifesciences Corporation between February 6, 2024, and July 24, 2024, are potentially eligible for compensation, as announced by Rosen Law Firm, a global investor rights legal practice. The firm, which focuses on securities class actions and shareholder derivative litigation, has set a lead plaintiff deadline of December 13, 2024. Anyone who acquired shares in Edwards Lifesciences during the said period might take part in the class action lawsuit without any out-of-pocket fees, as the costs are covered by a contingency fee arrangement. Those interested in joining … Read more